OptiNose, Inc. - stock earnings

OPTN Quarterly earnings

DateEarningsRevenue
2023Q4 -10.0 million USD 19.9 million USD
2023Q3 -9.3 million USD 19.8 million USD
2023Q2 2.6 million USD 19.5 million USD
2023Q1 -18.7 million USD 11.8 million USD
2022Q4 -17.3 million USD 20.9 million USD
2022Q3 -14.9 million USD 20.1 million USD
2022Q2 -19.4 million USD 20.6 million USD
2022Q1 -25.3 million USD 14.8 million USD
2021Q4 -15.6 million USD 22.5 million USD
2021Q3 -17.1 million USD 21.8 million USD
2021Q2 -23.5 million USD 18.4 million USD
2021Q1 -26.1 million USD 12.0 million USD
2020Q4 -23.9 million USD 16.3 million USD
2020Q3 -21.2 million USD 15.4 million USD
2020Q2 -25.9 million USD 10.3 million USD
2020Q1 -28.9 million USD 7.1 million USD
2019Q4 -25.0 million USD 11.1 million USD
2019Q3 -28.8 million USD 12.4 million USD
2019Q2 -27.4 million USD 6.7 million USD
2019Q1 -28.9 million USD 4.5 million USD
2018Q4 -26.4 million USD 3.0 million USD
2018Q3 -25.1 million USD 1.9 million USD
2018Q2 -24.6 million USD 1.3 million USD
2018Q1 -30.6 million USD 865000 USD
2017Q4 -19.6 million USD ? USD
2017Q3 -13.1 million USD 30000 USD
2017Q2 -8.2 million USD ? USD
2017Q1 -8.1 million USD ? USD
2016Q4 -5.6 million USD 47.5 million USD
2016Q3 -6.1 million USD 47.5 million USD
2016Q2 34.3 million USD 47.5 million USD
2015Q4 -28.3 million USD 85000 USD

OPTN Yearly earnings

DateEarningsRevenue
2023 -35.5 million USD 71.0 million USD
2022 -76.4 million USD 76.3 million USD
2021 -81.7 million USD 74.7 million USD
2020 -98.3 million USD 49.1 million USD
2019 -108.9 million USD 34.6 million USD
2018 -106.7 million USD 7.1 million USD
2017 -48.9 million USD 162000 USD
2016 22.6 million USD 47.5 million USD
2015 -28.3 million USD 85000 USD

OPTN

Price: $0.88

52 week price:
0.82
2.10

Earnings Per Share: -0.32 USD

P/E Ratio: -3.21

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 133800

Ebitda: -13.0 million

Market Capitalization: 139.7 million

Links: